Interstitial Lung Disease in Patients with Mixed Connective Tissue Disease: A Retrospective Study

References

• Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52(2):148–159. doi:10.1016/0002-9343(72)90064-2
   PubMed Web of Science ®Google Scholar
• Alves MR, Isenberg DA. “Mixed connective tissue disease”: a condition in search of an identity. Clin Exp Med. 2020;20(2):159–166. doi:10.1007/s10238-020-00606-7
   PubMed Web of Science ®Google Scholar
• Narula N, Narula T, Mira-Avendano I, Wang B, Abril A. Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement. Clin Exp Rheumatol. 2018;36(4):648–651.
   PubMed Web of Science ®Google Scholar
• Fagundes MN, Caleiro MT, Navarro-Rodriguez T, et al. Esophageal involvement and interstitial lung disease in mixed connective tissue disease. Respir Med. 2009;103(6):854–860. doi:10.1016/j.rmed.2008.12.018
   PubMed Web of Science ®Google Scholar
• Hyldgaard C, Bendstrup E, Pedersen AB, Pedersen L, Ellingsen T. Interstitial lung disease in connective tissue diseases: survival patterns in a population-based cohort. J Clin Med. 2021;10(21):4830. doi:10.3390/jcm10214830
   PubMed Web of Science ®Google Scholar
• D. Alarcón-Segovia and M. Villareal. Classification and diagnostic criteria for mixed connective tissue disease. In: Mixed Connective Tissue Disease and Antinuclear Antibodies. Amsterdam: Elsevier; 1987:3340.
   Google Scholar
• R. Kasukawa, T. Tojo, and S. Miyawaki. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Mixed Connective Tissue Disease and Antinuclear Antibodies. Amsterdam: Elsevier; 1987:41–47.
   Google Scholar
• Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–748. doi:10.1164/rccm.201308-1483ST
   PubMed Web of Science ®Google Scholar
• Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44–e68. doi:10.1164/rccm.201807-1255ST
   PubMed Web of Science ®Google Scholar
• Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18–e47. doi:10.1164/rccm.202202-0399ST
   PubMed Web of Science ®Google Scholar
• Aiko N, Yamakawa H, Iwasawa T, et al. Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease. Respir Investig. 2020;58(3):196–203. doi:10.1016/j.resinv.2019.12.003
   PubMed Web of Science ®Google Scholar
• Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156(10):684–691. doi:10.7326/0003-4819-156-10-201205150-00004
   PubMed Web of Science ®Google Scholar
• Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618–3731. doi:10.1093/eurheartj/ehac237
   PubMed Web of Science ®Google Scholar
• Humbert M, Kovacs G, Hoeper MM, et al. Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Eur Heart J. 2023;44(15):1312. doi:10.1093/eurheartj/ehad005
   PubMed Web of Science ®Google Scholar
• Waxman AB, Elia D, Adir Y, Humbert M, Harari S. Recent advances in the management of pulmonary hypertension with interstitial lung disease. Eur Respir Rev. 2022;31(165):210220. doi:10.1183/16000617.0220-2021
   PubMed Web of Science ®Google Scholar
• Hajas A, Szodoray P, Nakken B, et al. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol. 2013;40(7):1134–1142. doi:10.3899/jrheum.121272
   PubMed Web of Science ®Google Scholar
• Perelas A, Arrossi AV, Highland KB. Pulmonary manifestations of systemic sclerosis and mixed connective tissue disease. Clin Chest Med. 2019;40(3):501–518. doi:10.1016/j.ccm.2019.05.001
   PubMed Web of Science ®Google Scholar
• Gunnarsson R, Aaløkken TM, Molberg Ø, et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis. 2012;71(12):1966–1972. doi:10.1136/annrheumdis-2011-201253
   PubMed Web of Science ®Google Scholar
• Hetlevik SO, Flatø B, Aaløkken TM, et al. Pulmonary manifestations and progression of lung disease in juvenile-onset mixed connective tissue disease. J Rheumatol. 2019;46(1):93–100. doi:10.3899/jrheum.180019
   PubMed Web of Science ®Google Scholar
• Salaffi F, Di Carlo M, Carotti M, Fraticelli P, Gabrielli A, Giovagnoni A. Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study. Radiol med. 2018;123(9):655–663. doi:10.1007/s11547-018-0894-3
   PubMed Web of Science ®Google Scholar
• Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27(1):136–142. doi:10.1183/09031936.06.00037005
   PubMed Web of Science ®Google Scholar
• Sonnweber T, Pizzini A, Tancevski I, Löffler-Ragg J, Weiss G. Anaemia, iron homeostasis and pulmonary hypertension: a review. Intern Emerg Med. 2020;15(4):573–585. doi:10.1007/s11739-020-02288-1
   PubMed Web of Science ®Google Scholar
• Zanatta E, Polito P, Famoso G, et al. Pulmonary arterial hypertension in connective tissue disorders: pathophysiology and treatment. Exp Biol Med. 2019;244(2):120–131. doi:10.1177/1535370218824101
   PubMed Web of Science ®Google Scholar
• Crawford JH, Isbell TS, Huang Z, et al. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood. 2006;107(2):566–574. doi:10.1182/blood-2005-07-2668
   PubMed Web of Science ®Google Scholar
• Huang C, Li M, Liu Y, et al. Baseline characteristics and risk factors of pulmonary arterial hypertension in systemic lupus erythematosus patients. Medicine. 2016;95(10):e2761.
   PubMed Web of Science ®Google Scholar
• Cerik IB, Dindas F, Koyun E, et al. New prognostic markers in pulmonary arterial hypertension: CRP to albumin ratio and uric acid. Clin Biochem. 2022;100:22–28. doi:10.1016/j.clinbiochem.2021.11.004
   PubMed Web of Science ®Google Scholar
• Bao Y, Zhang W, Shi D, Bai W, He D, Wang D. Correlation between serum tumor marker levels and connective tissue disease-related interstitial lung disease. Int J Gen Med. 2021;14:2553–2560. doi:10.2147/IJGM.S310917
   PubMed Web of Science ®Google Scholar
• Vercauteren IM, Verleden SE, McDonough JE, et al. CYFRA 21.1 in bronchoalveolar lavage of idiopathic pulmonary fibrosis patients. Exp Lung Res. 2015;41(8):459–465. doi:10.3109/01902148.2015.1073407
   PubMed Web of Science ®Google Scholar
• Zheng M, Lou A, Zhang H, Zhu S, Yang M, Lai W. Serum KL-6, CA19-9, CA125 and CEA are diagnostic biomarkers for rheumatoid arthritis-associated interstitial lung disease in the Chinese Population. Rheumatol Ther. 2021;8(1):517–527. doi:10.1007/s40744-021-00288-x
   PubMed Web of Science ®Google Scholar
• Strieter RM, Mehrad B. New mechanisms of pulmonary fibrosis. Chest. 2009;136(5):1364–1370. doi:10.1378/chest.09-0510
   PubMed Web of Science ®Google Scholar
• Chan C, Ryerson CJ, Dunne JV, Wilcox PG. Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study. BMC Pulm Med. 2019;19(1):192. doi:10.1186/s12890-019-0943-2
   PubMed Web of Science ®Google Scholar
• Li X, Sun X, Huang Y, et al. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease. Clin Rheumatol. 2019;38(12):3619–3626. doi:10.1007/s10067-019-04690-3
   PubMed Web of Science ®Google Scholar